Fred Hassan

Fred Hassan

Directeur/Membre du Conseil chez PRECIGEN, INC.

Fortune : 11 M $ au 30/06/2026

80 ans
Health Technology
Consumer Services
Finance

Profil

Fred Hassan founded Caret Pharma LLC in 2017 and IM HealthScience LLC in 2010, where he is working as Chairman from 2010.
Mr. Hassan also founded Caret Group LLC, where he is working as Chairman.
Mr. Hassan also currently works at Saghmos Therapeutics, Inc., as Chairman from 2023, Physician's Seal LLC, as Non-Executive Chairman, Precigen, Inc., as Independent Director from 2016, Cocrystal Pharma, Inc., as Independent Director from 2023, BridgeBio Pharma, Inc., as Independent Director from 2021, EyePoint, Inc., as Independent Director from 2024, The Business Council, as Member, and Caerus Ventures LLC, as Advisor.
Mr. Hassan also formerly worked at Merck & Co., Inc., as Chairman, President & Chief Executive Officer from 2003 to 2009, Pharmacia & Upjohn, Inc., as President & Chief Executive Officer from 1997 to 2000, Schering-Plough Corp., as Chairman & Chief Executive Officer from 2003 to 2009, Pharmacia Corp., as Chairman & Chief Executive Officer from 2001 to 2003, Avon Products, Inc., as Non-Executive Chairman in 2013, Bausch & Lomb, Inc., as Non-Executive Chairman in 2013, Pharmaceutical Research & Manufacturers of America, as Chairman, Theramex HQ UK Ltd., as Chairman, Wyeth LLC, as Director & Executive Vice President from 1995 to 1997, Amgen, Inc., as Independent Director from 2015 to 2021, Electronic Data Systems Corp., as Director, Time Warner, Inc., as Independent Director from 2009 to 2018, Warburg Pincus LLC, as Managing Director, Bausch Health Cos., Inc., as Director from 2013 to 2014, Prometheus Biosciences, Inc., as Independent Director from 2021 to 2023, International Federation of Pharmaceutical Manufacturers, as President, Wyeth-Ayerst Laboratories, as President in 1993, and Sandoz Pharmaceuticals Corp., as Principal.
Mr. Hassan received his undergraduate degree from Imperial College London and Masters Business Admin degree from Harvard Business School.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
31/03/2026 1 243 239 ( 0,42 % ) 7 M $ 30/06/2026
22/06/2026 29 879 ( 0,02 % ) 2 M $ 30/06/2026
19/05/2026 1 380 992 ( 10,02 % ) 1 M $ 30/06/2026
21/04/2026 0 ( -.--% ) - $ 30/06/2026

Postes actifs de Fred Hassan

SociétésPosteDébut
PRECIGEN, INC. Directeur/Membre du Conseil 30/06/2016
BRIDGEBIO PHARMA, INC. Directeur/Membre du Conseil 17/08/2021
COCRYSTAL PHARMA, INC. Directeur/Membre du Conseil 20/04/2023
EYEPOINT, INC. Directeur/Membre du Conseil 03/09/2024
Consultant / Advisor -
Président 03/10/2023
Président -
Fondateur 01/01/2010
Fondateur -
░░░░░ ░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░

Anciens postes connus de Fred Hassan

SociétésPosteFin
░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░ ░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Fred Hassan

Formation de Fred Hassan

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

88

Relations au 1er degré

31

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées31

Health Technology

Health Technology

Consumer Non-Durables

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Technology Services

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Commercial Services

Sandoz Pharmaceuticals Corp.

Health Technology

Wyeth-Ayerst Laboratories

Consumer Services

Finance

Health Technology

Health Services

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Fred Hassan
🔇